サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1699146

間葉系幹細胞市場分析と2034年までの予測：タイプ、製品、サービス、技術、用途、エンドユーザー、プロセス、機能性

Mesenchymal Stem Cells Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Process, Functionality

出版日
ページ情報
英文 482 Pages
納期
3～5営業日
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.33円
間葉系幹細胞市場分析と2034年までの予測：タイプ、製品、サービス、技術、用途、エンドユーザー、プロセス、機能性
出版日: 2025年04月01日
発行: Global Insight Services
ページ情報: 英文 482 Pages
納期: 3～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

間葉系幹細胞市場は、2024年の34億米ドルから2034年には113億米ドルに拡大し、約12.8%のCAGRで成長すると予測されています。同市場は、再生および免疫調節特性で知られるMSCベースの治療法の開発、応用、商業化を包括しています。MSCは整形外科、心臓血管、自己免疫疾患など様々な疾患の治療に極めて重要です。細胞培養技術の進歩、臨床試験の増加、再生医療への投資の高まりが市場を牽引しています。規制状況や個別化医療への新たな応用がさらに成長を後押しし、治療風景を一変させるMSCの可能性を浮き彫りにしています。

市場概要：

間葉系幹細胞（MSCs）市場は、その多様な用途と大きな成長の可能性を特徴としています。再生医療と高度な治療ソリューションに対する需要の高まりにより、治療分野が主要市場セグメントとして浮上しています。このセグメントの優位性は、慢性疾患の有病率の増加、細胞ベースの治療法の進歩、心血管疾患、整形外科疾患、自己免疫疾患などの様々な病状の治療におけるMSCの受け入れの拡大に起因しています。細胞培養技術における技術的進歩や幹細胞生物学に対する理解の深まりが、このセグメントのリーダーシップをさらに強化しています。化粧品への応用や個別化医療へのMSCsのような新たなサブセグメントが牽引力を増しており、市場拡大の有望な道を提供しています。特にアンチエイジング治療や皮膚再生におけるMSCの美容応用は、非侵襲的な美容施術に対する消費者の需要の高まりにより、関心が高まっています。オーダーメイドの治療アプローチにMSCを活用する個別化医療は、変革の可能性を秘めており、患者固有の治療法に革命をもたらし、市場成長をさらに促進することが期待されています。

市場セグメンテーション
タイプ 自家、同種、異種
製品 細胞株、培養液、試薬およびキット
サービス セルバンキング、細胞特性解析、細胞分化
技術 細胞増殖、細胞分離、凍結保存
用途 再生医療、創薬、組織工学、整形外科、心臓血管、神経学、腫瘍学
エンドユーザー バイオ製薬会社、調査機関、病院、クリニック
プロセス インビトロ、インビボ
機能性 多能性、多能性

間葉系幹細胞市場は多様なセグメンテーションによって特徴付けられ、再生医療と細胞治療の需要増加に牽引され、治療用途セグメントが大きなシェアを占めています。また、幹細胞研究やバイオテクノロジーの進展により、研究用途分野も注目されています。地域別では、北米が強固なヘルスケアインフラと研究イニシアティブに後押しされて圧倒的な強さを維持している一方、アジア太平洋地域はヘルスケアとバイオテクノロジー分野への投資増加により加速度的な成長を遂げています。競合情勢は、ロンザ・グループ、サーモフィッシャーサイエンティフィック、STEMCELLテクノロジーズといった主要プレーヤーが、戦略的提携やイノベーションに積極的に取り組み、市場での地位を高めていることが特徴です。特に北米と欧州では、幹細胞治療の安全性と有効性を確保するために厳格なガイドラインが定められており、規制当局の影響は市場のダイナミクスを形成する上で極めて重要です。市場の見通しは楽観的であり、技術的進歩や臨床応用の増加によって持続的な成長が見込まれています。しかし、倫理的な懸念や規制の複雑さといった課題も依然として残っています。しかし、個別化医療や組織工学における画期的な進歩の可能性は、市場拡大の好機をもたらしています。

主要動向と促進要因：

間葉系幹細胞（MSC）市場は、再生医療と細胞治療の進歩に後押しされて力強い成長を遂げています。主な動向には、心血管疾患や自己免疫疾患などの慢性疾患の治療におけるMSCの統合の増加が含まれます。この急成長の背景には、損傷した組織を分化・修復するMSC細胞のユニークな能力があり、従来の治療に代わる有望な選択肢を提供しています。さらに、慢性疾患の世界の有病率の上昇は、革新的な治療法への需要を促進し、MSCをヘルスケアにおける重要な要素として位置づけています。市場はまた、研究開発への投資の高まりを目の当たりにしており、企業はMSCベースの治療法の有効性と安全性の向上に努めています。これは、臨床試験や承認を加速させる有利な規制的枠組みと相まっています。加えて、MSCの応用が従来のヘルスケアにとどまらず、化粧品やアンチエイジング治療のような分野へと拡大していることも、有利な機会をもたらしています。幹細胞治療の利点に対する消費者の認識が高まるにつれ、市場は大きく拡大する態勢が整いつつあります。スケーラブルな生産技術と費用対効果の高いソリューションに注力する企業は、こうした新たなビジネスチャンスを生かす好位置につけています。MSC市場は、革新と成長の両方が期待される、医学における変革の時代の最前線に立っています。

抑制と課題：

間葉系幹細胞市場には、いくつかの顕著な抑制要因と課題があります。重要なハードルは規制状況の厳しさであり、これが新規治療法の承認取得を複雑にし、市場投入までの時間を長くしています。高い生産コストがこの問題をさらに悪化させ、中小企業の競争と技術革新を困難にしています。加えて、製造工程が標準化されていないため、製品の品質や有効性にばらつきが生じています。長期的な安全性や有効性に関する臨床データやエビデンスが限られていることも、ヘルスケア関係者の間で広く採用され、受け入れられることを妨げています。さらに、幹細胞研究をめぐる倫理的な懸念は、社会的な議論を引き起こし続けており、規制当局の決定や資金調達に影響を及ぼす可能性があります。これらの課題は総じて、間葉系幹細胞市場の成長と発展にとって大きな障壁となっています。

目次

第1章 間葉系幹細胞市場の概要

  • 調査目的
  • 間葉系幹細胞市場の定義と調査範囲
  • レポートの限界
  • 調査対象年および通貨
  • 調査手法

第2章 エグゼクティブサマリー

第3章 市場に関する重要考察

第4章 間葉系幹細胞市場の展望

  • 間葉系幹細胞市場のセグメンテーション
  • 市場力学
  • ポーターのファイブフォース分析
  • PESTLE分析
  • バリューチェーン分析
  • 4Pモデル
  • ANSOFFマトリックス

第5章 間葉系幹細胞間葉系幹細胞市場戦略

  • 親市場分析
  • 需給分析
  • 消費者の購買意欲
  • ケーススタディ分析
  • 価格分析
  • 規制状況
  • サプライチェーン分析
  • 競合製品分析
  • 最近の動向

第6章 間葉系幹細胞の市場規模

  • 間葉系幹細胞の市場規模：金額別
  • 間葉系幹細胞の市場規模：数量別

第7章 間葉系幹細胞市場：タイプ別

  • 市場概要
  • 自家移植
  • 同種異系
  • 異種移植
  • その他

第8章 間葉系幹細胞市場：製品別

  • 市場概要
  • 細胞ライン
  • 培養培地
  • 試薬・キット
  • その他

第9章 間葉系幹細胞市場：サービス別

  • 市場概要
  • 細胞バンク
  • 細胞の特性化
  • 細胞分化
  • その他

第10章 間葉系幹細胞市場：技術別

  • 市場概要
  • 細胞拡大
  • 細胞単離
  • 凍結保存
  • その他

第11章 間葉系幹細胞市場：用途別

  • 市場概要
  • 再生医療
  • 創薬
  • 組織工学
  • 整形外科
  • 心臓血管
  • 神経学
  • 腫瘍学
  • その他

第12章 間葉系幹細胞市場：エンドユーザー別

  • 市場概要
  • バイオ医薬品企業
  • 研究機関
  • 病院およびクリニック
  • その他

第13章 間葉系幹細胞市場：プロセス別

  • 市場概要
  • インビトロ
  • 生体内
  • その他

第14章 間葉系幹細胞市場：機能別

  • 市場概要
  • 多能性
  • 万能性
  • その他

第15章 間葉系幹細胞市場：地域別

  • 概要
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • オランダ
    • スウェーデン
    • スイス
    • デンマーク
    • フィンランド
    • ロシア
    • その他欧州
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • オーストラリア
    • シンガポール
    • インドネシア
    • 台湾
    • マレーシア
    • その他アジア太平洋地域
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
    • その他ラテンアメリカ
  • 中東・アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • 南アフリカ
    • その他中東・アフリカ

第16章 競合情勢

  • 概要
  • 市場シェア分析
  • 主要企業のポジショニング
  • 競合リーダーシップマッピング
  • ベンダーベンチマーキング
  • 開発戦略のベンチマーキング

第17章 企業プロファイル

  • Cynata Therapeutics
  • Mesoblast
  • Athersys
  • Pluristem Therapeutics
  • Celltex Therapeutics
  • Stempeutics Research
  • BioCardia
  • Anterogen
  • Osiris Therapeutics
  • BrainStorm Cell Therapeutics
  • Promethera Biosciences
  • ReNeuron Group
  • Cellect Biotechnology
  • Steminent Biotherapeutics
  • Orbsen Therapeutics
  • Stemedica Cell Technologies
  • Cytori Therapeutics
  • Medipost
  • ThermoGenesis Holdings
  • American CryoStem
目次
Product Code: GIS25758

Mesenchymal Stem Cells Market is anticipated to expand from $3.4 billion in 2024 to $11.3 billion by 2034, growing at a CAGR of approximately 12.8%. The market encompasses the development, application, and commercialization of MSC-based therapies, known for their regenerative and immunomodulatory properties. MSCs are pivotal in treating various conditions, including orthopedic, cardiovascular, and autoimmune disorders. The market is driven by advancements in cell culture technologies, increasing clinical trials, and rising investments in regenerative medicine. Regulatory support and emerging applications in personalized medicine further propel growth, highlighting the potential of MSCs in transforming therapeutic landscapes.

Market Overview:

The Mesenchymal Stem Cells (MSCs) Market is characterized by its diverse applications and significant growth potential. The therapeutics segment emerges as the leading market segment, driven by the rising demand for regenerative medicine and advanced therapeutic solutions. This segment's dominance is attributed to the increasing prevalence of chronic diseases, advancements in cell-based therapies, and the growing acceptance of MSCs in treating various medical conditions, including cardiovascular, orthopedic, and autoimmune disorders. Technological advancements in cell culture techniques and enhanced understanding of stem cell biology further bolster this segment's leadership. Emerging sub-segments such as MSCs for cosmetic applications and personalized medicine are gaining traction, offering promising avenues for market expansion. The cosmetic application of MSCs, particularly in anti-aging treatments and skin regeneration, is witnessing increased interest due to the rising consumer demand for non-invasive aesthetic procedures. Personalized medicine, leveraging MSCs for tailored therapeutic approaches, holds transformative potential, promising to revolutionize patient-specific treatment modalities and further drive market growth.

Market Segmentation
TypeAutologous, Allogeneic, Xenogeneic
ProductCell Lines, Culture Media, Reagents and Kits
ServicesCell Banking, Cell Characterization, Cell Differentiation
TechnologyCell Expansion, Cell Isolation, Cryopreservation
ApplicationRegenerative Medicine, Drug Discovery, Tissue Engineering, Orthopedic, Cardiovascular, Neurology, Oncology
End UserBiopharmaceutical Companies, Research Institutes, Hospitals and Clinics
ProcessIn Vitro, In Vivo
FunctionalityMultipotent, Pluripotent

The Mesenchymal Stem Cells market is characterized by a diverse segmentation where the therapeutic applications segment holds a significant share, driven by the increasing demand for regenerative medicine and cell therapy. The research applications segment also commands attention due to ongoing advancements in stem cell research and biotechnology. Geographically, North America remains a dominant force, propelled by robust healthcare infrastructure and research initiatives, while the Asia-Pacific region is witnessing accelerated growth owing to rising investments in healthcare and biotechnology sectors. The competitive landscape is marked by the presence of key players such as Lonza Group, Thermo Fisher Scientific, and STEMCELL Technologies, who are actively engaged in strategic collaborations and innovations to enhance their market positions. Regulatory influences, particularly in North America and Europe, are pivotal in shaping market dynamics, with stringent guidelines ensuring the safety and efficacy of stem cell therapies. The market outlook is optimistic, with projections indicating sustained growth driven by technological advancements and increasing clinical applications. However, challenges such as ethical concerns and regulatory complexities persist, yet the potential for breakthroughs in personalized medicine and tissue engineering presents lucrative opportunities for market expansion.

Geographical Overview:

The Mesenchymal Stem Cells (MSC) market is witnessing varied growth patterns across different regions. North America remains at the forefront, driven by advanced healthcare infrastructure and substantial investments in regenerative medicine. The region's strong focus on research and development further propels market growth. In Europe, the MSC market is growing steadily. This growth is supported by increasing clinical trials and a robust regulatory framework fostering innovation. The region's emphasis on personalized medicine enhances its market potential. In the Asia Pacific, the MSC market is expanding rapidly. This growth is fueled by rising healthcare expenditures and a growing interest in stem cell research. Countries like China and Japan are investing heavily in stem cell therapies, contributing to the region's robust market dynamics. Latin America is an emerging market with increasing potential. The region is witnessing a surge in healthcare investments and growing awareness about stem cell therapies. The Middle East & Africa region is recognizing the importance of MSCs in advancing healthcare outcomes. Governments are investing in healthcare infrastructure, and there is a growing interest in regenerative medicine. This is paving the way for future market growth. Overall, each region presents unique opportunities and challenges, making the global MSC market a dynamic and promising landscape for stakeholders.

Recent Development:

The Mesenchymal Stem Cells (MSCs) market has witnessed several noteworthy developments in recent months. Lonza Group announced a strategic partnership with a leading biotech firm to enhance its MSC production capabilities, focusing on scaling up manufacturing processes for therapeutic applications. Meanwhile, Thermo Fisher Scientific has unveiled an innovative MSC product line, designed to improve cell viability and potency, which is expected to bolster their market position. In regulatory news, the FDA has issued new guidelines to streamline the approval process for MSC-based therapies, aiming to accelerate the delivery of safe and effective treatments to patients. Additionally, a joint venture between two prominent pharmaceutical companies is set to advance MSC research, with a focus on developing novel therapies for degenerative diseases. Lastly, a recent market analysis revealed an increasing investment trend in the MSC sector, driven by the rising demand for regenerative medicine solutions and the promising therapeutic potential of MSCs in various clinical applications.

Key Trends and Drivers:

The Mesenchymal Stem Cells (MSC) market is experiencing robust growth, propelled by advancements in regenerative medicine and cell therapy. Key trends include the increasing integration of MSCs in treating chronic diseases, such as cardiovascular and autoimmune disorders. This surge is driven by the cells' unique ability to differentiate and repair damaged tissues, offering a promising alternative to traditional treatments. Furthermore, the rising prevalence of chronic diseases globally is fostering demand for innovative therapies, positioning MSCs as a crucial component in the healthcare landscape. The market is also witnessing heightened investment in research and development, with companies striving to enhance the efficacy and safety of MSC-based therapies. This is coupled with favorable regulatory frameworks that are accelerating clinical trials and approvals. Additionally, the expansion of MSC applications beyond traditional healthcare into areas like cosmetic and anti-aging treatments presents lucrative opportunities. As consumer awareness regarding the benefits of stem cell therapies grows, the market is poised for significant expansion. Companies focusing on scalable production techniques and cost-effective solutions are well-positioned to capitalize on these emerging opportunities. The MSC market stands at the forefront of a transformative era in medical science, promising both innovation and growth.

Restraints and Challenges:

The mesenchymal stem cells market encounters several prominent restraints and challenges. A significant hurdle is the stringent regulatory landscape, which complicates approvals and prolongs time-to-market for new therapies. High production costs further exacerbate this issue, making it difficult for smaller companies to compete and innovate. Additionally, there is a lack of standardization in manufacturing processes, leading to variability in product quality and efficacy. Limited clinical data and evidence on long-term safety and effectiveness also hinder widespread adoption and acceptance among healthcare professionals. Furthermore, ethical concerns surrounding stem cell research continue to spark public debate and may influence regulatory decisions and funding. These challenges collectively pose significant barriers to the growth and advancement of the mesenchymal stem cells market.

Key Companies:

Cynata Therapeutics, Mesoblast, Athersys, Pluristem Therapeutics, Celltex Therapeutics, Stempeutics Research, Bio Cardia, Anterogen, Osiris Therapeutics, Brain Storm Cell Therapeutics, Promethera Biosciences, Re Neuron Group, Cellect Biotechnology, Steminent Biotherapeutics, Orbsen Therapeutics, Stemedica Cell Technologies, Cytori Therapeutics, Medipost, Thermo Genesis Holdings, American Cryo Stem

Sources:

National Institutes of Health (NIH), U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), World Health Organization (WHO), International Society for Stem Cell Research (ISSCR), International Society for Cellular Therapy (ISCT), Stem Cell Network, European Society of Gene and Cell Therapy (ESGCT), Harvard Stem Cell Institute, Stanford University School of Medicine, Mayo Clinic Center for Regenerative Medicine, University of California, San Francisco (UCSF) Stem Cell Center, Centre for Commercialization of Regenerative Medicine (CCRM), Japan Agency for Medical Research and Development (AMED), Regenerative Medicine Foundation, National Stem Cell Foundation, California Institute for Regenerative Medicine (CIRM), International Conference on Stem Cell and Regenerative Medicine, World Stem Cell Summit, Mesenchymal Stem Cell Conference

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Mesenchymal Stem Cells Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Mesenchymal Stem Cells Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Process
  • 2.10 Key Highlights of the Market, by Functionality
  • 2.11 Key Highlights of the Market, by North America
  • 2.12 Key Highlights of the Market, by Europe
  • 2.13 Key Highlights of the Market, by Asia-Pacific
  • 2.14 Key Highlights of the Market, by Latin America
  • 2.15 Key Highlights of the Market, by Middle East
  • 2.16 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Process
  • 3.9 Market Attractiveness Analysis, by Functionality
  • 3.10 Market Attractiveness Analysis, by North America
  • 3.11 Market Attractiveness Analysis, by Europe
  • 3.12 Market Attractiveness Analysis, by Asia-Pacific
  • 3.13 Market Attractiveness Analysis, by Latin America
  • 3.14 Market Attractiveness Analysis, by Middle East
  • 3.15 Market Attractiveness Analysis, by Africa

4: Mesenchymal Stem Cells Market Outlook

  • 4.1 Mesenchymal Stem Cells Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Mesenchymal Stem Cells Mesenchymal Stem Cells Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Mesenchymal Stem Cells Market Size

  • 6.1 Mesenchymal Stem Cells Market Size, by Value
  • 6.2 Mesenchymal Stem Cells Market Size, by Volume

7: Mesenchymal Stem Cells Market, by Type

  • 7.1 Market Overview
  • 7.2 Autologous
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Allogeneic
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Xenogeneic
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Others
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region

8: Mesenchymal Stem Cells Market, by Product

  • 8.1 Market Overview
  • 8.2 Cell Lines
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Culture Media
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Reagents and Kits
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Others
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region

9: Mesenchymal Stem Cells Market, by Services

  • 9.1 Market Overview
  • 9.2 Cell Banking
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Cell Characterization
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Cell Differentiation
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Others
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region

10: Mesenchymal Stem Cells Market, by Technology

  • 10.1 Market Overview
  • 10.2 Cell Expansion
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Cell Isolation
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Cryopreservation
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Others
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region

11: Mesenchymal Stem Cells Market, by Application

  • 11.1 Market Overview
  • 11.2 Regenerative Medicine
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Drug Discovery
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Tissue Engineering
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Orthopedic
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Cardiovascular
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Neurology
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region
  • 11.8 Oncology
    • 11.8.1 Key Market Trends & Opportunity Analysis
    • 11.8.2 Market Size and Forecast, by Region
  • 11.9 Others
    • 11.9.1 Key Market Trends & Opportunity Analysis
    • 11.9.2 Market Size and Forecast, by Region

12: Mesenchymal Stem Cells Market, by End User

  • 12.1 Market Overview
  • 12.2 Biopharmaceutical Companies
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Research Institutes
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Hospitals and Clinics
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Others
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region

13: Mesenchymal Stem Cells Market, by Process

  • 13.1 Market Overview
  • 13.2 In Vitro
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 In Vivo
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Others
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region

14: Mesenchymal Stem Cells Market, by Functionality

  • 14.1 Market Overview
  • 14.2 Multipotent
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Pluripotent
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Mesenchymal Stem Cells Market, by Region

  • 15.1 Overview
  • 15.2 North America
    • 15.2.1 Key Market Trends and Opportunities
    • 15.2.2 North America Market Size and Forecast, by Type
    • 15.2.3 North America Market Size and Forecast, by Product
    • 15.2.4 North America Market Size and Forecast, by Services
    • 15.2.5 North America Market Size and Forecast, by Technology
    • 15.2.6 North America Market Size and Forecast, by Application
    • 15.2.7 North America Market Size and Forecast, by End User
    • 15.2.8 North America Market Size and Forecast, by Process
    • 15.2.9 North America Market Size and Forecast, by Functionality
    • 15.2.10 North America Market Size and Forecast, by Country
    • 15.2.11 United States
      • 15.2.9.1 United States Market Size and Forecast, by Type
      • 15.2.9.2 United States Market Size and Forecast, by Product
      • 15.2.9.3 United States Market Size and Forecast, by Services
      • 15.2.9.4 United States Market Size and Forecast, by Technology
      • 15.2.9.5 United States Market Size and Forecast, by Application
      • 15.2.9.6 United States Market Size and Forecast, by End User
      • 15.2.9.7 United States Market Size and Forecast, by Process
      • 15.2.9.8 United States Market Size and Forecast, by Functionality
      • 15.2.9.9 Local Competition Analysis
      • 15.2.9.10 Local Market Analysis
    • 15.2.1 Canada
      • 15.2.10.1 Canada Market Size and Forecast, by Type
      • 15.2.10.2 Canada Market Size and Forecast, by Product
      • 15.2.10.3 Canada Market Size and Forecast, by Services
      • 15.2.10.4 Canada Market Size and Forecast, by Technology
      • 15.2.10.5 Canada Market Size and Forecast, by Application
      • 15.2.10.6 Canada Market Size and Forecast, by End User
      • 15.2.10.7 Canada Market Size and Forecast, by Process
      • 15.2.10.8 Canada Market Size and Forecast, by Functionality
      • 15.2.10.9 Local Competition Analysis
      • 15.2.10.10 Local Market Analysis
  • 15.1 Europe
    • 15.3.1 Key Market Trends and Opportunities
    • 15.3.2 Europe Market Size and Forecast, by Type
    • 15.3.3 Europe Market Size and Forecast, by Product
    • 15.3.4 Europe Market Size and Forecast, by Services
    • 15.3.5 Europe Market Size and Forecast, by Technology
    • 15.3.6 Europe Market Size and Forecast, by Application
    • 15.3.7 Europe Market Size and Forecast, by End User
    • 15.3.8 Europe Market Size and Forecast, by Process
    • 15.3.9 Europe Market Size and Forecast, by Functionality
    • 15.3.10 Europe Market Size and Forecast, by Country
    • 15.3.11 United Kingdom
      • 15.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 15.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 15.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 15.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 15.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 15.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 15.3.9.7 United Kingdom Market Size and Forecast, by Process
      • 15.3.9.8 United Kingdom Market Size and Forecast, by Functionality
      • 15.3.9.9 Local Competition Analysis
      • 15.3.9.10 Local Market Analysis
    • 15.3.1 Germany
      • 15.3.10.1 Germany Market Size and Forecast, by Type
      • 15.3.10.2 Germany Market Size and Forecast, by Product
      • 15.3.10.3 Germany Market Size and Forecast, by Services
      • 15.3.10.4 Germany Market Size and Forecast, by Technology
      • 15.3.10.5 Germany Market Size and Forecast, by Application
      • 15.3.10.6 Germany Market Size and Forecast, by End User
      • 15.3.10.7 Germany Market Size and Forecast, by Process
      • 15.3.10.8 Germany Market Size and Forecast, by Functionality
      • 15.3.10.9 Local Competition Analysis
      • 15.3.10.10 Local Market Analysis
    • 15.3.1 France
      • 15.3.11.1 France Market Size and Forecast, by Type
      • 15.3.11.2 France Market Size and Forecast, by Product
      • 15.3.11.3 France Market Size and Forecast, by Services
      • 15.3.11.4 France Market Size and Forecast, by Technology
      • 15.3.11.5 France Market Size and Forecast, by Application
      • 15.3.11.6 France Market Size and Forecast, by End User
      • 15.3.11.7 France Market Size and Forecast, by Process
      • 15.3.11.8 France Market Size and Forecast, by Functionality
      • 15.3.11.9 Local Competition Analysis
      • 15.3.11.10 Local Market Analysis
    • 15.3.1 Spain
      • 15.3.12.1 Spain Market Size and Forecast, by Type
      • 15.3.12.2 Spain Market Size and Forecast, by Product
      • 15.3.12.3 Spain Market Size and Forecast, by Services
      • 15.3.12.4 Spain Market Size and Forecast, by Technology
      • 15.3.12.5 Spain Market Size and Forecast, by Application
      • 15.3.12.6 Spain Market Size and Forecast, by End User
      • 15.3.12.7 Spain Market Size and Forecast, by Process
      • 15.3.12.8 Spain Market Size and Forecast, by Functionality
      • 15.3.12.9 Local Competition Analysis
      • 15.3.12.10 Local Market Analysis
    • 15.3.1 Italy
      • 15.3.13.1 Italy Market Size and Forecast, by Type
      • 15.3.13.2 Italy Market Size and Forecast, by Product
      • 15.3.13.3 Italy Market Size and Forecast, by Services
      • 15.3.13.4 Italy Market Size and Forecast, by Technology
      • 15.3.13.5 Italy Market Size and Forecast, by Application
      • 15.3.13.6 Italy Market Size and Forecast, by End User
      • 15.3.13.7 Italy Market Size and Forecast, by Process
      • 15.3.13.8 Italy Market Size and Forecast, by Functionality
      • 15.3.13.9 Local Competition Analysis
      • 15.3.13.10 Local Market Analysis
    • 15.3.1 Netherlands
      • 15.3.14.1 Netherlands Market Size and Forecast, by Type
      • 15.3.14.2 Netherlands Market Size and Forecast, by Product
      • 15.3.14.3 Netherlands Market Size and Forecast, by Services
      • 15.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 15.3.14.5 Netherlands Market Size and Forecast, by Application
      • 15.3.14.6 Netherlands Market Size and Forecast, by End User
      • 15.3.14.7 Netherlands Market Size and Forecast, by Process
      • 15.3.14.8 Netherlands Market Size and Forecast, by Functionality
      • 15.3.14.9 Local Competition Analysis
      • 15.3.14.10 Local Market Analysis
    • 15.3.1 Sweden
      • 15.3.15.1 Sweden Market Size and Forecast, by Type
      • 15.3.15.2 Sweden Market Size and Forecast, by Product
      • 15.3.15.3 Sweden Market Size and Forecast, by Services
      • 15.3.15.4 Sweden Market Size and Forecast, by Technology
      • 15.3.15.5 Sweden Market Size and Forecast, by Application
      • 15.3.15.6 Sweden Market Size and Forecast, by End User
      • 15.3.15.7 Sweden Market Size and Forecast, by Process
      • 15.3.15.8 Sweden Market Size and Forecast, by Functionality
      • 15.3.15.9 Local Competition Analysis
      • 15.3.15.10 Local Market Analysis
    • 15.3.1 Switzerland
      • 15.3.16.1 Switzerland Market Size and Forecast, by Type
      • 15.3.16.2 Switzerland Market Size and Forecast, by Product
      • 15.3.16.3 Switzerland Market Size and Forecast, by Services
      • 15.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 15.3.16.5 Switzerland Market Size and Forecast, by Application
      • 15.3.16.6 Switzerland Market Size and Forecast, by End User
      • 15.3.16.7 Switzerland Market Size and Forecast, by Process
      • 15.3.16.8 Switzerland Market Size and Forecast, by Functionality
      • 15.3.16.9 Local Competition Analysis
      • 15.3.16.10 Local Market Analysis
    • 15.3.1 Denmark
      • 15.3.17.1 Denmark Market Size and Forecast, by Type
      • 15.3.17.2 Denmark Market Size and Forecast, by Product
      • 15.3.17.3 Denmark Market Size and Forecast, by Services
      • 15.3.17.4 Denmark Market Size and Forecast, by Technology
      • 15.3.17.5 Denmark Market Size and Forecast, by Application
      • 15.3.17.6 Denmark Market Size and Forecast, by End User
      • 15.3.17.7 Denmark Market Size and Forecast, by Process
      • 15.3.17.8 Denmark Market Size and Forecast, by Functionality
      • 15.3.17.9 Local Competition Analysis
      • 15.3.17.10 Local Market Analysis
    • 15.3.1 Finland
      • 15.3.18.1 Finland Market Size and Forecast, by Type
      • 15.3.18.2 Finland Market Size and Forecast, by Product
      • 15.3.18.3 Finland Market Size and Forecast, by Services
      • 15.3.18.4 Finland Market Size and Forecast, by Technology
      • 15.3.18.5 Finland Market Size and Forecast, by Application
      • 15.3.18.6 Finland Market Size and Forecast, by End User
      • 15.3.18.7 Finland Market Size and Forecast, by Process
      • 15.3.18.8 Finland Market Size and Forecast, by Functionality
      • 15.3.18.9 Local Competition Analysis
      • 15.3.18.10 Local Market Analysis
    • 15.3.1 Russia
      • 15.3.19.1 Russia Market Size and Forecast, by Type
      • 15.3.19.2 Russia Market Size and Forecast, by Product
      • 15.3.19.3 Russia Market Size and Forecast, by Services
      • 15.3.19.4 Russia Market Size and Forecast, by Technology
      • 15.3.19.5 Russia Market Size and Forecast, by Application
      • 15.3.19.6 Russia Market Size and Forecast, by End User
      • 15.3.19.7 Russia Market Size and Forecast, by Process
      • 15.3.19.8 Russia Market Size and Forecast, by Functionality
      • 15.3.19.9 Local Competition Analysis
      • 15.3.19.10 Local Market Analysis
    • 15.3.1 Rest of Europe
      • 15.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 15.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 15.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 15.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 15.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 15.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 15.3.20.7 Rest of Europe Market Size and Forecast, by Process
      • 15.3.20.8 Rest of Europe Market Size and Forecast, by Functionality
      • 15.3.20.9 Local Competition Analysis
      • 15.3.20.10 Local Market Analysis
  • 15.1 Asia-Pacific
    • 15.4.1 Key Market Trends and Opportunities
    • 15.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 15.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 15.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 15.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 15.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 15.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 15.4.8 Asia-Pacific Market Size and Forecast, by Process
    • 15.4.9 Asia-Pacific Market Size and Forecast, by Functionality
    • 15.4.10 Asia-Pacific Market Size and Forecast, by Country
    • 15.4.11 China
      • 15.4.9.1 China Market Size and Forecast, by Type
      • 15.4.9.2 China Market Size and Forecast, by Product
      • 15.4.9.3 China Market Size and Forecast, by Services
      • 15.4.9.4 China Market Size and Forecast, by Technology
      • 15.4.9.5 China Market Size and Forecast, by Application
      • 15.4.9.6 China Market Size and Forecast, by End User
      • 15.4.9.7 China Market Size and Forecast, by Process
      • 15.4.9.8 China Market Size and Forecast, by Functionality
      • 15.4.9.9 Local Competition Analysis
      • 15.4.9.10 Local Market Analysis
    • 15.4.1 India
      • 15.4.10.1 India Market Size and Forecast, by Type
      • 15.4.10.2 India Market Size and Forecast, by Product
      • 15.4.10.3 India Market Size and Forecast, by Services
      • 15.4.10.4 India Market Size and Forecast, by Technology
      • 15.4.10.5 India Market Size and Forecast, by Application
      • 15.4.10.6 India Market Size and Forecast, by End User
      • 15.4.10.7 India Market Size and Forecast, by Process
      • 15.4.10.8 India Market Size and Forecast, by Functionality
      • 15.4.10.9 Local Competition Analysis
      • 15.4.10.10 Local Market Analysis
    • 15.4.1 Japan
      • 15.4.11.1 Japan Market Size and Forecast, by Type
      • 15.4.11.2 Japan Market Size and Forecast, by Product
      • 15.4.11.3 Japan Market Size and Forecast, by Services
      • 15.4.11.4 Japan Market Size and Forecast, by Technology
      • 15.4.11.5 Japan Market Size and Forecast, by Application
      • 15.4.11.6 Japan Market Size and Forecast, by End User
      • 15.4.11.7 Japan Market Size and Forecast, by Process
      • 15.4.11.8 Japan Market Size and Forecast, by Functionality
      • 15.4.11.9 Local Competition Analysis
      • 15.4.11.10 Local Market Analysis
    • 15.4.1 South Korea
      • 15.4.12.1 South Korea Market Size and Forecast, by Type
      • 15.4.12.2 South Korea Market Size and Forecast, by Product
      • 15.4.12.3 South Korea Market Size and Forecast, by Services
      • 15.4.12.4 South Korea Market Size and Forecast, by Technology
      • 15.4.12.5 South Korea Market Size and Forecast, by Application
      • 15.4.12.6 South Korea Market Size and Forecast, by End User
      • 15.4.12.7 South Korea Market Size and Forecast, by Process
      • 15.4.12.8 South Korea Market Size and Forecast, by Functionality
      • 15.4.12.9 Local Competition Analysis
      • 15.4.12.10 Local Market Analysis
    • 15.4.1 Australia
      • 15.4.13.1 Australia Market Size and Forecast, by Type
      • 15.4.13.2 Australia Market Size and Forecast, by Product
      • 15.4.13.3 Australia Market Size and Forecast, by Services
      • 15.4.13.4 Australia Market Size and Forecast, by Technology
      • 15.4.13.5 Australia Market Size and Forecast, by Application
      • 15.4.13.6 Australia Market Size and Forecast, by End User
      • 15.4.13.7 Australia Market Size and Forecast, by Process
      • 15.4.13.8 Australia Market Size and Forecast, by Functionality
      • 15.4.13.9 Local Competition Analysis
      • 15.4.13.10 Local Market Analysis
    • 15.4.1 Singapore
      • 15.4.14.1 Singapore Market Size and Forecast, by Type
      • 15.4.14.2 Singapore Market Size and Forecast, by Product
      • 15.4.14.3 Singapore Market Size and Forecast, by Services
      • 15.4.14.4 Singapore Market Size and Forecast, by Technology
      • 15.4.14.5 Singapore Market Size and Forecast, by Application
      • 15.4.14.6 Singapore Market Size and Forecast, by End User
      • 15.4.14.7 Singapore Market Size and Forecast, by Process
      • 15.4.14.8 Singapore Market Size and Forecast, by Functionality
      • 15.4.14.9 Local Competition Analysis
      • 15.4.14.10 Local Market Analysis
    • 15.4.1 Indonesia
      • 15.4.15.1 Indonesia Market Size and Forecast, by Type
      • 15.4.15.2 Indonesia Market Size and Forecast, by Product
      • 15.4.15.3 Indonesia Market Size and Forecast, by Services
      • 15.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 15.4.15.5 Indonesia Market Size and Forecast, by Application
      • 15.4.15.6 Indonesia Market Size and Forecast, by End User
      • 15.4.15.7 Indonesia Market Size and Forecast, by Process
      • 15.4.15.8 Indonesia Market Size and Forecast, by Functionality
      • 15.4.15.9 Local Competition Analysis
      • 15.4.15.10 Local Market Analysis
    • 15.4.1 Taiwan
      • 15.4.16.1 Taiwan Market Size and Forecast, by Type
      • 15.4.16.2 Taiwan Market Size and Forecast, by Product
      • 15.4.16.3 Taiwan Market Size and Forecast, by Services
      • 15.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 15.4.16.5 Taiwan Market Size and Forecast, by Application
      • 15.4.16.6 Taiwan Market Size and Forecast, by End User
      • 15.4.16.7 Taiwan Market Size and Forecast, by Process
      • 15.4.16.8 Taiwan Market Size and Forecast, by Functionality
      • 15.4.16.9 Local Competition Analysis
      • 15.4.16.10 Local Market Analysis
    • 15.4.1 Malaysia
      • 15.4.17.1 Malaysia Market Size and Forecast, by Type
      • 15.4.17.2 Malaysia Market Size and Forecast, by Product
      • 15.4.17.3 Malaysia Market Size and Forecast, by Services
      • 15.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 15.4.17.5 Malaysia Market Size and Forecast, by Application
      • 15.4.17.6 Malaysia Market Size and Forecast, by End User
      • 15.4.17.7 Malaysia Market Size and Forecast, by Process
      • 15.4.17.8 Malaysia Market Size and Forecast, by Functionality
      • 15.4.17.9 Local Competition Analysis
      • 15.4.17.10 Local Market Analysis
    • 15.4.1 Rest of Asia-Pacific
      • 15.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 15.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 15.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 15.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 15.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 15.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 15.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 15.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Functionality
      • 15.4.18.9 Local Competition Analysis
      • 15.4.18.10 Local Market Analysis
  • 15.1 Latin America
    • 15.5.1 Key Market Trends and Opportunities
    • 15.5.2 Latin America Market Size and Forecast, by Type
    • 15.5.3 Latin America Market Size and Forecast, by Product
    • 15.5.4 Latin America Market Size and Forecast, by Services
    • 15.5.5 Latin America Market Size and Forecast, by Technology
    • 15.5.6 Latin America Market Size and Forecast, by Application
    • 15.5.7 Latin America Market Size and Forecast, by End User
    • 15.5.8 Latin America Market Size and Forecast, by Process
    • 15.5.9 Latin America Market Size and Forecast, by Functionality
    • 15.5.10 Latin America Market Size and Forecast, by Country
    • 15.5.11 Brazil
      • 15.5.9.1 Brazil Market Size and Forecast, by Type
      • 15.5.9.2 Brazil Market Size and Forecast, by Product
      • 15.5.9.3 Brazil Market Size and Forecast, by Services
      • 15.5.9.4 Brazil Market Size and Forecast, by Technology
      • 15.5.9.5 Brazil Market Size and Forecast, by Application
      • 15.5.9.6 Brazil Market Size and Forecast, by End User
      • 15.5.9.7 Brazil Market Size and Forecast, by Process
      • 15.5.9.8 Brazil Market Size and Forecast, by Functionality
      • 15.5.9.9 Local Competition Analysis
      • 15.5.9.10 Local Market Analysis
    • 15.5.1 Mexico
      • 15.5.10.1 Mexico Market Size and Forecast, by Type
      • 15.5.10.2 Mexico Market Size and Forecast, by Product
      • 15.5.10.3 Mexico Market Size and Forecast, by Services
      • 15.5.10.4 Mexico Market Size and Forecast, by Technology
      • 15.5.10.5 Mexico Market Size and Forecast, by Application
      • 15.5.10.6 Mexico Market Size and Forecast, by End User
      • 15.5.10.7 Mexico Market Size and Forecast, by Process
      • 15.5.10.8 Mexico Market Size and Forecast, by Functionality
      • 15.5.10.9 Local Competition Analysis
      • 15.5.10.10 Local Market Analysis
    • 15.5.1 Argentina
      • 15.5.11.1 Argentina Market Size and Forecast, by Type
      • 15.5.11.2 Argentina Market Size and Forecast, by Product
      • 15.5.11.3 Argentina Market Size and Forecast, by Services
      • 15.5.11.4 Argentina Market Size and Forecast, by Technology
      • 15.5.11.5 Argentina Market Size and Forecast, by Application
      • 15.5.11.6 Argentina Market Size and Forecast, by End User
      • 15.5.11.7 Argentina Market Size and Forecast, by Process
      • 15.5.11.8 Argentina Market Size and Forecast, by Functionality
      • 15.5.11.9 Local Competition Analysis
      • 15.5.11.10 Local Market Analysis
    • 15.5.1 Rest of Latin America
      • 15.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 15.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 15.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 15.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 15.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 15.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 15.5.12.7 Rest of Latin America Market Size and Forecast, by Process
      • 15.5.12.8 Rest of Latin America Market Size and Forecast, by Functionality
      • 15.5.12.9 Local Competition Analysis
      • 15.5.12.10 Local Market Analysis
  • 15.1 Middle East and Africa
    • 15.6.1 Key Market Trends and Opportunities
    • 15.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 15.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 15.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 15.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 15.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 15.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 15.6.8 Middle East and Africa Market Size and Forecast, by Process
    • 15.6.9 Middle East and Africa Market Size and Forecast, by Functionality
    • 15.6.10 Middle East and Africa Market Size and Forecast, by Country
    • 15.6.11 Saudi Arabia
      • 15.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 15.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 15.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 15.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 15.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 15.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 15.6.9.7 Saudi Arabia Market Size and Forecast, by Process
      • 15.6.9.8 Saudi Arabia Market Size and Forecast, by Functionality
      • 15.6.9.9 Local Competition Analysis
      • 15.6.9.10 Local Market Analysis
    • 15.6.1 UAE
      • 15.6.10.1 UAE Market Size and Forecast, by Type
      • 15.6.10.2 UAE Market Size and Forecast, by Product
      • 15.6.10.3 UAE Market Size and Forecast, by Services
      • 15.6.10.4 UAE Market Size and Forecast, by Technology
      • 15.6.10.5 UAE Market Size and Forecast, by Application
      • 15.6.10.6 UAE Market Size and Forecast, by End User
      • 15.6.10.7 UAE Market Size and Forecast, by Process
      • 15.6.10.8 UAE Market Size and Forecast, by Functionality
      • 15.6.10.9 Local Competition Analysis
      • 15.6.10.10 Local Market Analysis
    • 15.6.1 South Africa
      • 15.6.11.1 South Africa Market Size and Forecast, by Type
      • 15.6.11.2 South Africa Market Size and Forecast, by Product
      • 15.6.11.3 South Africa Market Size and Forecast, by Services
      • 15.6.11.4 South Africa Market Size and Forecast, by Technology
      • 15.6.11.5 South Africa Market Size and Forecast, by Application
      • 15.6.11.6 South Africa Market Size and Forecast, by End User
      • 15.6.11.7 South Africa Market Size and Forecast, by Process
      • 15.6.11.8 South Africa Market Size and Forecast, by Functionality
      • 15.6.11.9 Local Competition Analysis
      • 15.6.11.10 Local Market Analysis
    • 15.6.1 Rest of MEA
      • 15.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 15.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 15.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 15.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 15.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 15.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 15.6.12.7 Rest of MEA Market Size and Forecast, by Process
      • 15.6.12.8 Rest of MEA Market Size and Forecast, by Functionality
      • 15.6.12.9 Local Competition Analysis
      • 15.6.12.10 Local Market Analysis

16: Competitive Landscape

  • 16.1 Overview
  • 16.2 Market Share Analysis
  • 16.3 Key Player Positioning
  • 16.4 Competitive Leadership Mapping
    • 16.4.1 Star Players
    • 16.4.2 Innovators
    • 16.4.3 Emerging Players
  • 16.5 Vendor Benchmarking
  • 16.6 Developmental Strategy Benchmarking
    • 16.6.1 New Product Developments
    • 16.6.2 Product Launches
    • 16.6.3 Business Expansions
    • 16.6.4 Partnerships, Joint Ventures, and Collaborations
    • 16.6.5 Mergers and Acquisitions

17: Company Profiles

  • 17.1 Cynata Therapeutics
    • 17.1.1 Company Overview
    • 17.1.2 Company Snapshot
    • 17.1.3 Business Segments
    • 17.1.4 Business Performance
    • 17.1.5 Product Offerings
    • 17.1.6 Key Developmental Strategies
    • 17.1.7 SWOT Analysis
  • 17.2 Mesoblast
    • 17.2.1 Company Overview
    • 17.2.2 Company Snapshot
    • 17.2.3 Business Segments
    • 17.2.4 Business Performance
    • 17.2.5 Product Offerings
    • 17.2.6 Key Developmental Strategies
    • 17.2.7 SWOT Analysis
  • 17.3 Athersys
    • 17.3.1 Company Overview
    • 17.3.2 Company Snapshot
    • 17.3.3 Business Segments
    • 17.3.4 Business Performance
    • 17.3.5 Product Offerings
    • 17.3.6 Key Developmental Strategies
    • 17.3.7 SWOT Analysis
  • 17.4 Pluristem Therapeutics
    • 17.4.1 Company Overview
    • 17.4.2 Company Snapshot
    • 17.4.3 Business Segments
    • 17.4.4 Business Performance
    • 17.4.5 Product Offerings
    • 17.4.6 Key Developmental Strategies
    • 17.4.7 SWOT Analysis
  • 17.5 Celltex Therapeutics
    • 17.5.1 Company Overview
    • 17.5.2 Company Snapshot
    • 17.5.3 Business Segments
    • 17.5.4 Business Performance
    • 17.5.5 Product Offerings
    • 17.5.6 Key Developmental Strategies
    • 17.5.7 SWOT Analysis
  • 17.6 Stempeutics Research
    • 17.6.1 Company Overview
    • 17.6.2 Company Snapshot
    • 17.6.3 Business Segments
    • 17.6.4 Business Performance
    • 17.6.5 Product Offerings
    • 17.6.6 Key Developmental Strategies
    • 17.6.7 SWOT Analysis
  • 17.7 BioCardia
    • 17.7.1 Company Overview
    • 17.7.2 Company Snapshot
    • 17.7.3 Business Segments
    • 17.7.4 Business Performance
    • 17.7.5 Product Offerings
    • 17.7.6 Key Developmental Strategies
    • 17.7.7 SWOT Analysis
  • 17.8 Anterogen
    • 17.8.1 Company Overview
    • 17.8.2 Company Snapshot
    • 17.8.3 Business Segments
    • 17.8.4 Business Performance
    • 17.8.5 Product Offerings
    • 17.8.6 Key Developmental Strategies
    • 17.8.7 SWOT Analysis
  • 17.9 Osiris Therapeutics
    • 17.9.1 Company Overview
    • 17.9.2 Company Snapshot
    • 17.9.3 Business Segments
    • 17.9.4 Business Performance
    • 17.9.5 Product Offerings
    • 17.9.6 Key Developmental Strategies
    • 17.9.7 SWOT Analysis
  • 17.10 BrainStorm Cell Therapeutics
    • 17.10.1 Company Overview
    • 17.10.2 Company Snapshot
    • 17.10.3 Business Segments
    • 17.10.4 Business Performance
    • 17.10.5 Product Offerings
    • 17.10.6 Key Developmental Strategies
    • 17.10.7 SWOT Analysis
  • 17.11 Promethera Biosciences
    • 17.11.1 Company Overview
    • 17.11.2 Company Snapshot
    • 17.11.3 Business Segments
    • 17.11.4 Business Performance
    • 17.11.5 Product Offerings
    • 17.11.6 Key Developmental Strategies
    • 17.11.7 SWOT Analysis
  • 17.12 ReNeuron Group
    • 17.12.1 Company Overview
    • 17.12.2 Company Snapshot
    • 17.12.3 Business Segments
    • 17.12.4 Business Performance
    • 17.12.5 Product Offerings
    • 17.12.6 Key Developmental Strategies
    • 17.12.7 SWOT Analysis
  • 17.13 Cellect Biotechnology
    • 17.13.1 Company Overview
    • 17.13.2 Company Snapshot
    • 17.13.3 Business Segments
    • 17.13.4 Business Performance
    • 17.13.5 Product Offerings
    • 17.13.6 Key Developmental Strategies
    • 17.13.7 SWOT Analysis
  • 17.14 Steminent Biotherapeutics
    • 17.14.1 Company Overview
    • 17.14.2 Company Snapshot
    • 17.14.3 Business Segments
    • 17.14.4 Business Performance
    • 17.14.5 Product Offerings
    • 17.14.6 Key Developmental Strategies
    • 17.14.7 SWOT Analysis
  • 17.15 Orbsen Therapeutics
    • 17.15.1 Company Overview
    • 17.15.2 Company Snapshot
    • 17.15.3 Business Segments
    • 17.15.4 Business Performance
    • 17.15.5 Product Offerings
    • 17.15.6 Key Developmental Strategies
    • 17.15.7 SWOT Analysis
  • 17.16 Stemedica Cell Technologies
    • 17.16.1 Company Overview
    • 17.16.2 Company Snapshot
    • 17.16.3 Business Segments
    • 17.16.4 Business Performance
    • 17.16.5 Product Offerings
    • 17.16.6 Key Developmental Strategies
    • 17.16.7 SWOT Analysis
  • 17.17 Cytori Therapeutics
    • 17.17.1 Company Overview
    • 17.17.2 Company Snapshot
    • 17.17.3 Business Segments
    • 17.17.4 Business Performance
    • 17.17.5 Product Offerings
    • 17.17.6 Key Developmental Strategies
    • 17.17.7 SWOT Analysis
  • 17.18 Medipost
    • 17.18.1 Company Overview
    • 17.18.2 Company Snapshot
    • 17.18.3 Business Segments
    • 17.18.4 Business Performance
    • 17.18.5 Product Offerings
    • 17.18.6 Key Developmental Strategies
    • 17.18.7 SWOT Analysis
  • 17.19 ThermoGenesis Holdings
    • 17.19.1 Company Overview
    • 17.19.2 Company Snapshot
    • 17.19.3 Business Segments
    • 17.19.4 Business Performance
    • 17.19.5 Product Offerings
    • 17.19.6 Key Developmental Strategies
    • 17.19.7 SWOT Analysis
  • 17.20 American CryoStem
    • 17.20.1 Company Overview
    • 17.20.2 Company Snapshot
    • 17.20.3 Business Segments
    • 17.20.4 Business Performance
    • 17.20.5 Product Offerings
    • 17.20.6 Key Developmental Strategies
    • 17.20.7 SWOT Analysis